Lesion characteristics based on medical therapy at discharge
| DAPT (+) (n=189) | DAPT (−) (n=88) | P value | Cilostazol (+) (n=84) | Cilostazol (−) (n=193) | P value | |
| Reference vessel diameter, mm | 5.8±0.9 | 5.7±0.7 | 0.193 | 5.7±0.8 | 5.8±0.9 | 0.149 |
| Lesion length, mm | 129.0±98.7 | 116.1±95.1 | 0.307 | 136.4±99.8 | 119.9±96.4 | 0.198 |
| Chronic total occlusion, % | 42.8 | 42.9 | 0.991 | 48.7 | 40.4 | 0.211 |
| Severe calcification, % | 14.3 | 20.5 | 0.014 | 20.2 | 14.5 | 0.542 |
| Extent of lesion, % | ||||||
| Proximal SFA | 23.8 | 21.6 | 0.309 | 16.7 | 25.9 | 0.556 |
| Distal SFA | 34.9 | 46.6 | 42.9 | 36.8 | ||
| Above-the-knee PA | 4.2 | 6.8 | 3.6 | 5.7 | ||
| Entire SFA | 30.7 | 20.5 | 29.8 | 26.4 | ||
| Distal SFA and above-the-knee PA | 2.1 | 2.3 | 2.4 | 2.1 | ||
| Entire SFA and above-the-knee PA | 4.2 | 2.3 | 4.8 | 3.1 | ||
| Number of stents used | 1.6±0.9 | 1.6±0.9 | 0.875 | 1.7±0.9 | 1.6±0.9 | 0.294 |
PA, popliteal artery; SFA, superficial femoral artery.